The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia

Anesthesia and Analgesia

Volumn 108, Issue 3, 2009, Pages 751-758

  Lang, Thomas ^a,b   Johanning, Kai ^b   Metzler, Helfried ^b   Piepenbrock, Siegfried ^c   Solomon, Cristina ^d   Rahe Meyer, Niels ^a   Tanaka, Kenichi A ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Werlhof Institut   (Germany)

^c University Medical School   (Australia)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHALASIN; FIBRIN; FIBRINOGEN; DIAGNOSTIC AGENT;

ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD CLOTTING; BLOOD SAMPLING; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; DIAGNOSTIC TEST; ELASTICITY; FIBRINOGEN BLOOD LEVEL; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; POLYMERIZATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; THROMBOCYTE RICH PLASMA; THROMBOCYTOPENIA; THROMBOELASTOMETRY; BLOOD; METABOLISM; PHYSIOLOGY; THROMBOELASTOGRAPHY;

BLOOD COAGULATION; CYTOCHALASINS; ELASTICITY; FIBRINOGEN; HUMANS; PLATELET COUNT; RETROSPECTIVE STUDIES; THROMBELASTOGRAPHY; THROMBOCYTOPENIA;

EID: 61949353495     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181966675     Document Type: Article

References (36)

1. Hoffman M, Monroe DM 3rd. A cell-based model of hemostasis. Thromb Haemost 2001;85:958-65
2. Ruggeri ZM. The role of von Willebrand factor and fibrinogen in the initiation of platelet adhesion to thrombogenic surfaces. Thromb Haemost 1995;74:460-3
3. Ruggeri ZM. Mechanisms initiating platelet thrombus formation. Thromb Haemost 1997;78:611-6
4. Katori N, Tanaka KA, Szlam F, Levy JH. The effects of platelet count on clot retraction and tissue plasminogen activatorinduced fibrinolysis on thrombelastography. Anesth Analg 2005;100:1781-5
5. Lang T, Toller W, Gutl M, Mahla E, Metzler H, Rehak P, Marz W, Halwachs-Baumann G. Different effects of abciximab and cytochalasin D on clot strength in thrombelastography. J Thromb Haemost 2004;2:147-53
6. Ray MJ, Hawson GA, Just SJ, McLachlan G, O'Brien M. Relationship of platelet aggregation to bleeding after cardiopulmonary bypass. Ann Thorac Surg 1994;57:981-6
7. Sarode R, Rawal A, Lee R, Shen YM, Frenkel EP. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy. Br J Haematol 2006;132:604-7
8. Spiess BD, Royston D, Levy JH, Fitch J, Dietrich W, Body S, Murkin J, Nadel A. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 2004;44:1143-8
9. Gajic O, Rana R, Winters JL, Yilmaz M, Mendez JL, Rickman OB, O'Byrne MM, Evenson LK, Malinchoc M, DeGoey SR, Afessa B, Hubmayr RD, Moore SB. Transfusion related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med 2007;176:886-9
10. Nuttall GA, Oliver WC, Santrach PJ, Bryant S, Dearani JA, Schaff HV, Ereth MH. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 2001;94:773-81
11. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999;88:312-9
12. Kettner SC, Panzer OP, Kozek SA, Seibt FA, Stoiser B, Kofler J, Locker GJ, Zimpfer M. Use of abciximab-modified thrombelastography in patients undergoing cardiac surgery. Anesth Analg 1999;89:580-4
13. Fries D, Krismer A, Klingler A, Streif W, Klima G, Wenzel V, Haas T, Innerhofer P. Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. Br J Anaesth 2005;95:172-7
14. Tanaka KA, Taketomi T, Szlam F, Calatzis A, Levy JH. Improved clot formation by combined administration of activated factor VII (NovoSeven-) and fibrinogen (Haemocomplettan- P). Anesth Analg 2008;106:732-8
15. Khurana S, Mattson JC, Westley S, O'Neill WW, Timmis GC, Safian RD. Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography. J Lab Clin Med 1997;130:401-11
16. Nielsen VG, Geary BT, Baird MS. Evaluation of the contribution of platelets to clot strength by thromboelastography in rabbits: the role of tissue factor and cytochalasin D. Anesth Analg 2000;91:35-9
17. Lang T, Bauters A, Braun SL, Potzsch B, von Pape KW, Kolde HJ, Lakner M. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005;16:301-10
18. Gottumukkala VN, Sharma SK, Philip J. Assessing platelet and fibrinogen contribution to clot strength using modified thromboelastography in pregnant women. Anesth Analg 1999; 89:1453-5
19. Nielsen VG, Cohen BM, Cohen E. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII. Acta Anaesthesiol Scand 2005;49:222-31
20. Plow EF, Haas TA, Zhang L, Loftus J, Smith JW. Ligand binding to integrins. J Biol Chem 2000;275:21785-8
21. Chun R, Poon MC, Haigh J, Seal D, Donahue B, Royston D. Case 1-2005: cardiac surgery in congenital afibrinogenemia with thrombo-occlusive disease. J Cardiothorac Vasc Anesth 2005;19:109-17
22. Elodi S, Varadi K. Optimization of conditions for the catalytic effect of the factor IXa-factor VIII complex: probable role of the complex in the amplification of blood coagulation. Thromb Res 1979;15:617-29
23. Wagner CL, Mascelli MA, Neblock DS, Weisman HF, Coller BS, Jordan RE. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood 1996;88:907-14
24. Slichter SJ. Relationship between platelet count and bleeding risk in thrombocytopenic patients. Transfusion Med Rev 2004;18:153-67
25. Chakroun T, Gerotziafas GT, Seghatchian J, Samama MM, Hatmi M, Elalamy I. The influence of fibrin polymerization and platelet-mediated contractile forces on citrated whole blood thromboelastography profile. Thromb Haemost 2006;95:822-8
26. Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein IIb-IIIa complex. Blood 1988;71:831-43
27. Mann KG, Butenas S, Brummel K. The dynamics of thrombin formation. Arterioscler Thromb Vasc Biol 2003;23:17-25
28. Poon MC, D'Oiron R. Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. Blood Coagul Fibrinolysis 2000;11:S55-S68
29. Lincoff AM, LeNarz LA, Despotis GJ, Smith PK, Booth JE, Raymond RE, Sapp SK, Cabot CF, Tcheng JE, Califf RM, Effron MB, Topol EJ. Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve long-term outcome with abciximab GP IIb/IIIa blockade. Evaluation of platelet IIb/IIIa inhibition in STENTing. Ann Thorac Surg 2000;70:516-26
30. Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, Hynes RO, Wagner DD. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 2000;106:385-92
31. Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H, Sibony O, Mahieu-Caputo D, Hurtaud-Roux MF, Huisse MG, Denninger MH, de Prost D. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007;5:266-73
32. Velik-Salchner C, Haas T, Innerhofer P, Streif W, Nussbaumer W, Klingler A, Klima G, Martinowitz U, Fries D. The effect of fibrinogen concentrate on thrombocytopenia. J Thromb Haemost 2007;5:1019-25
33. Meade TW. Fibrinogen measurement to assess the risk of arterial thrombosis in individual patients: yes. J Thromb Haemost 2005;3:632-4
34. Lowe GD. Fibrinogen measurement to assess the risk of arterial thrombosis in individual patients: not yet. J Thromb Haemost 2005;3:635-7
35. Reinhart WH. Fibrinogen-marker or mediator of vascular disease? Vasc Med 2003;8:211-6
36. Hiippala ST. Dextran and hydroxyethyl starch interfere with fibrinogen assays. Blood Coagul Fibrinolysis 1995;6:743-6